Table 3.
The most frequent side effects reported by PAH/CTEPH patients after the first and second doses of vaccination against COVID-19.
| AEs | After First Dose (n = 200) n (%) |
After Second Dose (n = 197) n (%) |
|---|---|---|
| Pain at the site of injection | 101 (50.5) | 56 (28.5) |
| fever | 35 (17.5) | 21 (10.5) |
| fatique | 29 (14.5) | 26 (13) |
| myalgia | 16 (8) | 12 (6) |
| chills | 16 (8) | 8 (4) |
| headache | 12 (6) | 11 (6) |
| other | 11 (5.5) | 10 (5) |
PAH—pulmonary arterial hypertension, CTEPH—chronic thromboembolic pulmonary hypertension, AE—adverse event.